Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHR160 spray in severe asthma
IRCT20220610055122N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of PHR160 in severe asthma, sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoints: FEV1, FVC and 3 more. Started Oct 2022; status: completed.
02
Drugs
PHR160
03
Conditions
severe asthma
Beyond the preview
Go deeper on IRCT20220610055122N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220610055122N1.